Jury Awards $40 Million to Plaintiff in Bellwether Verdict in Bard Implanted Port Catheter MDL
prweb.com · 2026-09-11
A federal jury in the District of Arizona returned a unanimous verdict awarding plaintiff Kimberly Divelbliss compensatory damages in the amount of $40 million...
TickrTrends take: Becton Dickinson faces a significant legal liability exposure following the bellwether verdict in its implanted port catheter litigation, with a jury awarding 40 million dollars to a plaintiff in the multidistrict litigation. This judgment establishes a potential precedent for numerous other cases in the MDL and introduces material downside risk to the company's future earnings and cash flow that investors should monitor closely. TickrTrends currently rates BDX as undervalued, but shareholders should track how additional verdicts and settlement estimates evolve, as mounting legal costs could materially alter the company's financial profile and warrant a reassessment of this valuation thesis.
Read the full story at prweb.com →
Is BDX undervalued? See TickrTrends' fair value analysis →